[ Price : $8.95]
FDA warns San Diego-based Dexcom about Quality System violations in its production of unapproved glucose monitors.[ Price : $8.95]
FDA warns Indias Aspen Biopharma about CGMP deviations in its manufacturing of active pharmaceutical ingredients.[ Price : $8.95]
Smiths Medical recalls its oral/nasal endotracheal tubes after becoming aware that certain device sizes may have a smaller diamete...[ Price : $8.95]
Cassava Sciences reports topline results from the Phase 3 REFOCUS-ALZ study of simufilam in mild-to-moderate Alzheimers disease, s...[ Price : $8.95]
FDA researchers examine the use of confirmatory evidence with one adequate and well-controlled trial in non-oncologic drug rare di...[ Price : $8.95]
FDA selects former consultant Barclay Butler as its deputy commissioner for operations and chief operating officer.[ Price : $8.95]
Advantage Silver Dental Arrest asks FDA to rescind medical device approvals for silver diamine fluoride and silver fluoride agents...[ Price : $8.95]
Axsome says its solriamfetol met the primary and secondary endpoints in the Phase 3 FOCUS trial in attention deficit hyperactivity...